e-learning
resources
Munich 2006
Tuesday 05.09.2006
Epidemiology, diagnosis and treatment of multidrug-resistant tuberculosis (MDR-TB)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
MDR TB in Macedonia in the last five years
A. A. Vidoevska, S. J. Talevski, C. D. Vragoterova (Skopje, Fyrom)
Source:
Annual Congress 2006 - Epidemiology, diagnosis and treatment of multidrug-resistant tuberculosis (MDR-TB)
Session:
Epidemiology, diagnosis and treatment of multidrug-resistant tuberculosis (MDR-TB)
Session type:
Poster Discussion
Number:
3446
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. A. Vidoevska, S. J. Talevski, C. D. Vragoterova (Skopje, Fyrom). MDR TB in Macedonia in the last five years. Eur Respir J 2006; 28: Suppl. 50, 3446
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Multy-drug resistance tuberculosis (MDR-TB) in Federation of Bosnia and Herzegovina during ten years
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
The hundred years of combat against tuberculosis in Hungary
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
Outcomes of MDR cases in Iasi county, Romania
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Multidrug-resistance TB in Armenia
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Child‘s tuberculosis in Ukraine: 10 years of epidemic
Source: Eur Respir J 2006; 28: Suppl. 50, 15s
Year: 2006
Treatment outcome of multi-drug resistant tuberculosis in the Republic of Moldova
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Multidrug–resistant tuberculosis in Czech Republic during the period of recent 5 years (2007-2012)
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Our experience with multiple drug-resistant tuberculosis in Plovdiv Region, Bulgaria – 1999–2004
Source: Eur Respir J 2006; 28: Suppl. 50, 379s
Year: 2006
Trend in TB control in Republic of Moldova: High MDRTB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Drug-resistant tuberculosis trend in Centre-North Sardinia in the last 11 years
Source: Annual Congress 2008 - COPD and miscellaneous
Year: 2008
The evolution of TB among economic immigrants in Greece the last 11 years
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009
The development of tuberculosis in Bucharest in the last ten years
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011
Extrapulmonary tuberculosis (TB): 40 years observations in Poland
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
How big is the problem with MDR-TB cases in Macedonia?
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Tuberculosis in Estonia: a major impact of Russian MDR Mycobacterium tuberculosis Beijing B0/W148-cluster
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Features of different M.tuberculosis strains that were isolated from MDR-TB patients in Kharkiv, Ukraine
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Nationwide anti-tuberculosis drug resistance survey in the Republic of Azerbaijan
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
XDR and MDR-TB genetic markers of M. tuberculosis strains circulating in Kyrgyz Republic
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
Trend of acquired drug resistance to main anti TB drugs in the first 7 years of applying DOT strategy in Iasi County, Romania
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept